kinpeygo
stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarrheals, soole põletikuvastased / antiinfective ained - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
giona easyhaler inhalatsioonipulber
orion corporation - budesoniid - inhalatsioonipulber - 200mcg 1annus 200annus 3tk; 200mcg 1annus 200annus 2tk; 200mcg 1annus 200annus 1tk
giona easyhaler inhalatsioonipulber
orion corporation - budesoniid - inhalatsioonipulber - 400mcg 1annus 100annus 3tk; 400mcg 1annus 100annus 2tk
giona easyhaler inhalatsioonipulber
orion corporation - budesoniid - inhalatsioonipulber - 100mcg 1annus 200annus 3tk; 100mcg 1annus 200annus 1tk; 100mcg 1annus 200annus 2tk
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
bufar easyhaler inhalatsioonipulber
orion corporation - formoterool+budesoniid - inhalatsioonipulber - 4,5mcg+80mcg 1annus 60annus 1tk; 4,5mcg+80mcg 1annus 60annus 3tk; 4,5mcg+80mcg 1annus 120annus 1tk; 4,5mcg+80mcg 1annus 120annus 3tk
symbicort turbuhaler inhalatsioonipulber
astrazeneca ab - formoterool+budesoniid - inhalatsioonipulber - 4,5mcg+80mcg 1annus 120annus 3tk; 4,5mcg+80mcg 1annus 60annus 1tk; 4,5mcg+80mcg 1annus 120annus 1tk; 4,5mcg+80mcg 1annus 60annus 18tk; 4,5mcg+80mcg 1annus 60annus 2tk; 4,5mcg+80mcg 1annus 60annus 10tk; 4,5mcg+80mcg 1annus 120annus 10tk; 4,5mcg+80mcg 1annus 120annus 18tk; 4,5mcg+80mcg 1annus 60annus 3tk
symbicort turbuhaler inhalatsioonipulber
astrazeneca ab - formoterool+budesoniid - inhalatsioonipulber - 4,5mcg+160mcg 1annus 120annus 10tk; 4,5mcg+160mcg 1annus 60annus 1tk; 4,5mcg+160mcg 1annus 120annus 18tk; 4,5mcg+160mcg 1annus 60annus 18tk; 4,5mcg+160mcg 1annus 60annus 2tk; 4,5mcg+160mcg 1annus 120annus 3tk; 4,5mcg+160mcg 1annus 60annus 3tk; 4,5mcg+160mcg 1annus 60annus 10tk; 4,5mcg+160mcg 1annus 120annus 2tk; 4,5mcg+160mcg 1annus 30annus 1tk; 4,5mcg+160mcg 1annus 120annus 1tk
symbicort turbuhaler inhalatsioonipulber
astrazeneca ab - formoterool+budesoniid - inhalatsioonipulber - 9mcg+320mcg 1annus 60annus 10tk; 9mcg+320mcg 1annus 60annus 18tk; 9mcg+320mcg 1annus 60annus 1tk